Jounce Therapeutics to Announce Second Quarter 2021 Financial Results and Host a Conference Call on Thursday, August 5, 2021
CAMBRIDGE, Mass., July 29, 2021 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, today announced that it will report second quarter 2021 financial results and provide a corporate update before market open on Thursday, August 5, 2021. Jounce Therapeutics’ management team will host a live conference call and webcast at 8:00am ET.
Conference Call and Webcast
About Jounce Therapeutics
Investor and Media Contacts:
Keynote Presentation - Open to all Badge Holders
Smart City: Keeping Citizens Safe and Happy
Brunch Served in ITEXPO #TECHSUPERSHOW Expo Hall